The United States Food and Drug Administration (FDA) has approved Susvimo (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the treatment
The Cornea and Contact Lens Society of Australia (CCLSA) will present its penultimate webinar for this year on 31 October via Zoom.
A new initiative launched by Glaucoma Australia, aims to raise funds to help end glaucoma blindness.
Targeted nutrition can significantly reduce ‘eye floaters’ as well as their associated discomforts, in certain patients, according to a study published in the ARVO
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
